Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with PCV2 infection

TW202641835APending Publication Date: 2026-10-16BOEHRINGER INGELHEIM VETMEDICA GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143038
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-06
Filing Date
2025-11-05
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080585_001
    Figure TWG2TA001080585_001
  • Figure TWG2TA001080585_002
    Figure TWG2TA001080585_002
  • Figure TWG2TA001080585_003
    Figure TWG2TA001080585_003
Patent Text Reader

Abstract

(PCV2) infection in a pig, the method comprising administering orally to the pig an immunogenic composition comprising non-replicating PCV2 antigen. In one example, an immunogenic composition is administered via the oral route to a pig, wherein the immunogenic composition comprises a recombinantly produced and purified PCV2 ORF2 protein. This allows to simply reduce virus shedding, colonization of lymphoid tissue, and / or lymphoid depletion caused by associated with a PCV2 infection in the pigs, while simultaneously reducing the propensity for adverse reactions, eliminating the risk of injection site reactions, avoiding pain, and putting less stress on the animals.
Need to check novelty before this filing date? Find Prior Art